Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Joy

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
The Breast Journal|August 27, 2019
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKaren A Gelmon, Massimo Cristofanilli, Hope S Rugo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2018
Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studiesHope S Rugo, Nicholas C Turner, Richard S Finn, et al.
Clinical Breast Cancer|April 9, 2021
Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast CancerAnil A Joy, Larissa J Vos, Edith Pituskin, et al.
Micromachines|March 14, 2020
How to Ease the Pain of Taking a Diagnostic Point of Care Test to the Market: A Framework for Evidence DevelopmentSara Graziadio, Amanda Winter, B Clare Lendrem, et al.
Breast Cancer Research and Treatment|January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-upH S Rugo, R S Finn, V Diéras, et al.
Journal of Medical Internet Research|March 24, 2025
Acceptability and Effectiveness of a Fully Web-Based Nutrition and Exercise Program for Individuals With Chronic Disease During COVID-19: Randomized Controlled TrialPuneeta Tandon, Kathleen P Ismond, Graeme Purdy, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patientsJuan A Pérez-Bermejo, Serah Kang, Sarah J Rockwood, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2018
A prospective intervention to improve happiness and reduce burnout in oncologistsMark Clemons, Sasha Mazzarello, Gregory Pond, et al.
Blood|September 30, 2004
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populationsJohn R Mackey, Carlos M Galmarini, Kathryn A Graham, et al.
Diagnostic and Prognostic Research|May 19, 2021
Conducting invasive urodynamics in primary care: qualitative interview study examining experiences of patients and healthcare professionalsSarah Milosevic, Natalie Joseph-Williams, Bethan Pell, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
The Breast Journal|August 27, 2019
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKaren A Gelmon, Massimo Cristofanilli, Hope S Rugo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2018
Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studiesHope S Rugo, Nicholas C Turner, Richard S Finn, et al.
Clinical Breast Cancer|April 9, 2021
Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast CancerAnil A Joy, Larissa J Vos, Edith Pituskin, et al.
Micromachines|March 14, 2020
How to Ease the Pain of Taking a Diagnostic Point of Care Test to the Market: A Framework for Evidence DevelopmentSara Graziadio, Amanda Winter, B Clare Lendrem, et al.
Breast Cancer Research and Treatment|January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-upH S Rugo, R S Finn, V Diéras, et al.
Journal of Medical Internet Research|March 24, 2025
Acceptability and Effectiveness of a Fully Web-Based Nutrition and Exercise Program for Individuals With Chronic Disease During COVID-19: Randomized Controlled TrialPuneeta Tandon, Kathleen P Ismond, Graeme Purdy, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patientsJuan A Pérez-Bermejo, Serah Kang, Sarah J Rockwood, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2018
A prospective intervention to improve happiness and reduce burnout in oncologistsMark Clemons, Sasha Mazzarello, Gregory Pond, et al.
Blood|September 30, 2004
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populationsJohn R Mackey, Carlos M Galmarini, Kathryn A Graham, et al.
Diagnostic and Prognostic Research|May 19, 2021
Conducting invasive urodynamics in primary care: qualitative interview study examining experiences of patients and healthcare professionalsSarah Milosevic, Natalie Joseph-Williams, Bethan Pell, et al.
Pageof 28